CER Medical Institute is a private organization dedicated to the prevention, diagnosis, treatment and research of prevalent diseases.
Our expertise in training, innovation and medical humanism make our institution an integral health system that brings science and technique closer to the community with one goal, to improve people's quality of life.
A new report by Analysis Group, "Innovation in the Biopharmaceutical Pipeline: A Multi-Dimensional View", examines the pipeline from several different angles to capture the breadth and focus of ongoing research and to describe the array of potential new treatments and cures for patients.
The inaugural C.R.O.W.N SummiT in 2012 was an overwhelming success due to the large turnout of passionate executives eager to collaborate in the C.R.O.W.N. atmosphere and improve their craft. 2013 provides...
As many as 30% of subjects in Phase III clinical studies drop out. Gruelling schedules, high travel costs and time waiting for expense reimbursement can all be factors in these fall rates, and this can be...
Until recently, clinical trials were concentrated in developed countries. The number of patients enrolled in international multi-centre clinical trials has increased in some countries of Latin America.
